Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook

40°
- Newton, NC (28658)
  Today
  
  Clear skies. Low 27F. Winds light and variable..
  
  Tonight
  
  Clear skies. Low 27F. Winds light and variable.
  
  Updated: February 9, 2026 @ 8:06 pm
- Full Forecast

Site search

Home
News
Sports
Obituaries
Classifieds
- Place an ad
e-Edition
Best of 2025
Archives

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

14.97 -0.02 (-0.13%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Summit Therapeutics Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Why Is AbbVie Stock Trading Higher On Thursday? ↗

July 10, 2025

AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase clinical data.

Via Benzinga

Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug ↗

July 09, 2025

Merck is acquiring Verona Pharma for $10 billion, gaining COPD drug Ohtuvayre as part of its strategy to offset Keytruda's looming patent loss.

Via Benzinga

Topics Intellectual Property

NIKE, Datadog And Snap Are Among Top 11 Large Cap Gainers Last Week (June 30-July 4): Are The Others In Your Portfolio? ↗

July 06, 2025

11 best performing large-cap stocks last week, including Symbotic, Nike, First Solar, Datadog, HPE, Summit Therapeutics, Carnival, POSCO, Wynn Resorts, SharkNinja, and Snap

Via Benzinga

2 Soaring Stocks With More Upside Potential to Buy and Hold ↗

July 04, 2025

Via The Motley Fool

Why AstraZeneca Stock Got Thumped on Thursday ↗

July 03, 2025

Via The Motley Fool

Why Summit Therapeutics Stock Soared 8% Higher Today ↗

July 03, 2025

Via The Motley Fool

AstraZeneca In $15B Talks For Drug That Could Upend Lung Cancer Treatment ↗

July 03, 2025

Via Benzinga

AstraZeneca In Talks To License Summit Therapeutics’ Experimental Lung Cancer Drug: Report ↗

July 03, 2025

While the terms of the partnership agreement are still being negotiated, it could include an upfront payment worth several billion dollars and milestone payments, Bloomberg reported, while noting that...

Via Stocktwits

2 Dividend Stocks to Buy and Never Sell ↗

June 18, 2025

Via The Motley Fool

Topics Lawsuit

Why Summit Therapeutics Stock Tanked Today ↗

June 11, 2025

Via The Motley Fool

This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗

June 11, 2025

Via Benzinga

Why Casey's General Stores Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗

June 10, 2025

Via Benzinga

2 Soaring Stocks Wth More Upside Potential ↗

June 05, 2025

Via The Motley Fool

3 No-Brainer Healthcare Stocks to Buy in June ↗

June 02, 2025

Via The Motley Fool

Is Beaten-Down Summit Therapeutics Stock a Bad-News Buy? ↗

June 02, 2025

Via The Motley Fool

Temu Parent PDD, Regeneron Pharmaceutical And Burlington Stores Are Among Top 11 Large-Cap Losers Last Week (May 26-May 30): Are The Others In Your Portfolio? ↗

June 01, 2025

11 large-cap stocks with worst performance in last week: SMMT, PDD, REGN, BAH, OKTA, DECK, CPRT, COO, TPL, HPQ, BURL. Mixed results, lowered forecasts.

Via Benzinga

Which stocks are experiencing notable movement on Friday? ↗

May 30, 2025

Curious to know what's happening on the US markets one hour before the close of the markets on Friday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

Dow Edges Higher; Dell Shares Fall After Q1 Results ↗

May 30, 2025

Via Benzinga

Topics Stocks

Why Summit Therapeutics Plunged Today ↗

May 30, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 30, 2025

Via Benzinga

Top movers in Friday's session ↗

May 30, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Summit Therapeutics Stock Tumbles On Oncology Drug Trial Data, Retail Flags ‘Insane’ Valuation ↗

May 30, 2025

Summit now intends to file a Biologics License Application (BLA) with the U.S. Food and Drug Administration seeking approval for Ivonescimab plus chemotherapy based on the results of the trial.

Via Stocktwits

Topics Lawsuit Regulatory Compliance

Traders are paying attention to the gapping stocks in Friday's session. ↗

May 30, 2025

Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.

Via Chartmill

Summit Therapeutics, A Top 1% Biotech, Plummets On A High-Profile Failure ↗

May 30, 2025

There's a long history of anti-PD-1 and anti-VEGF drugs working to slow progression, but not improve overall survival.

Via Investor's Business Daily

Summit Therapeutics' Closely-Watched Lung Cancer Study Of Ivonescimab Misses Overall Survival Endpoint ↗

May 30, 2025

Summit Therapeutics' Phase 3 trial met the primary goal in lung cancer, showing significant PFS benefit with ivonescimab plus chemotherapy.

Via Benzinga

3 High-Flying Stocks That Could Soar Even More ↗

May 24, 2025

Via The Motley Fool

Treasury Yields Top 5%: These 20 Stocks Tanked In Just One Hour ↗

May 21, 2025

The selloff came as investors repriced risk across equities amid fears of persistently higher rates, sparked by soft demand at the 20-year Treasury auction.

Via Benzinga

Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 ↗

May 21, 2025

Via The Motley Fool

Topics Economy Law Enforcement

Got $100? 3 Top Growth Stocks to Buy That Could Double Your Money ↗

May 18, 2025

Via The Motley Fool

Topics Artificial Intelligence

Eli Lilly, Affirm And Regeneron Are Among Top 12 Large-Cap Losers Last Week (May 5-May 9): Are The Others In Your Portfolio? ↗

May 11, 2025

The worst performing large-cap stocks last week: ARGENX, VRTX, SMMT, MMYT, REGN, RKT, BNTX, AFRM, FNF, LLY, AUR, DASH. Any in your portfolio?

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

13 14 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

Home
News
Sports
Entertainment
e-Edition
Announcements
Obituaries
Multimedia
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Calendar
Email Alerts
Search
Weather

Contact Information

ObserverNewsOnline.com
309 North College Avenue
Newton, NC 28658
Phone: 828-464-0221
Email: admanager@observernewsonline.com

Facebook

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Newton, NC (28658)

Today

Tonight

Summit Therapeutics Inc. - Common Stock (NQ:SMMT)

Headline News about Summit Therapeutics Inc. - Common Stock

Sections

Services

Contact Information

Follow Us